Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
29.82B | 30.36B | 28.72B | 22.14B | 19.71B | Gross Profit |
10.51B | 10.70B | 11.36B | 8.57B | 7.15B | EBIT |
3.52B | 3.23B | 4.08B | 3.31B | 2.02B | EBITDA |
5.29B | 5.15B | 6.41B | 6.39B | 2.59B | Net Income Common Stockholders |
978.00M | 2.30B | 2.68B | 3.32B | -204.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.35B | 2.38B | 2.77B | 3.25B | 4.00B | Total Assets |
53.77B | 55.15B | 53.42B | 49.82B | 43.52B | Total Debt |
0.00 | 18.24B | 16.38B | 16.87B | 18.20B | Net Debt |
-2.35B | 15.86B | 13.61B | 13.63B | 14.20B | Total Liabilities |
31.37B | 32.36B | 31.50B | 30.12B | 29.12B | Stockholders Equity |
19.58B | 20.06B | 19.55B | 17.36B | 13.39B |
Cash Flow | Free Cash Flow | |||
3.04B | 1.75B | 2.48B | 2.58B | 1.50B | Operating Cash Flow |
5.50B | 4.43B | 4.50B | 4.18B | 3.14B | Investing Cash Flow |
-2.44B | -3.58B | -2.68B | -2.29B | -1.44B | Financing Cash Flow |
-2.57B | -816.00M | -2.74B | -2.87B | 1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $141.70B | 24.35 | 7.31% | 1.47% | 0.64% | 10.02% | |
78 Outperform | $38.56B | 14.72 | 15.09% | 3.67% | 1.25% | -13.02% | |
77 Outperform | $48.46B | 45.46 | 4.99% | 1.74% | -1.73% | -57.46% | |
71 Outperform | $2.37B | 13.27 | 11.33% | 3.45% | 6.18% | 61.39% | |
67 Neutral | $9.74B | 9.66 | 7.90% | 3.91% | -5.17% | -0.74% | |
65 Neutral | $26.90B | 15.91 | -6.21% | 3.23% | 0.96% | 4.38% | |
61 Neutral | $28.73B | 49.10 | -0.98% | 2.51% | 2.47% | -105.09% |